Integrative Signaling by Minimal Erythropoietin Receptor Forms and c-Kit*

Erythroid homeostasis depends critically upon erythropoietin (Epo) and stem cell factor cosignaling in late progenitor cells. Epo bioresponses are relayed efficiently by minimal receptor forms that retain a single Tyr-343 site for STAT5 binding, while forms that lack all cytoplasmic Tyr(P) sites activate JAK2 and the transcription of c-Myc plus presumed additional target genes. In FDCER cell lines, which express endogenous c-Kit, the signaling capacities of such minimal Epo receptor forms (ER-HY343 and ER-HY343F) have been dissected to reveal: 1) that Epo-dependent mitogenesis, survival, and bcl-x gene expression via ER-HY343 depend upon the intactness of the Tyr-343 STAT5 binding site; 2) that ER-HY343-dependent bcl-xL gene transcription is enhanced markedly via c-Kit; 3) thatsocs-3, plfap, dpp-1, andcacy-bp gene transcription is induced via ER-HY343, whereasdpp-1 and cacy-bp gene expression is also supported by ER-HY343F; 4) that ectopically expressed SOCS-3 suppresses proliferative signaling by not only ER-HY343 but also c-Kit; and 5) that in FDCER and primary erythroid cells, c-Kit appears to provide the primary route to MAPK activation. Thus, integration circuits exist in only select downstream pathways within Epo and stem call factor receptor signaling.

[1]  R. Gregory,et al.  Subtraction cloning and initial characterization of novel epo-immediate response genes. , 2000, Cytokine.

[2]  X. W. Wang,et al.  Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin , 2000, British Journal of Cancer.

[3]  D. Waxman,et al.  SOCS/CIS Protein Inhibition of Growth Hormone-stimulated STAT5 Signaling by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.

[4]  L. Mei,et al.  Neuregulin‐Increased Expression of Acetylcholine Receptorε‐Subunit Gene Requires ErbB Interaction with Shc , 1999 .

[5]  R. Gregory,et al.  Signal transduction in the erythropoietin receptor system. , 1999, Experimental cell research.

[6]  D. Wojchowski,et al.  A minimal cytoplasmic subdomain of the erythropoietin receptor mediates erythroid and megakaryocytic cell development. , 1999, Blood.

[7]  H. Pendeville,et al.  SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis , 1999, Cell.

[8]  A. Mui,et al.  STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells , 1999, The EMBO journal.

[9]  F. Prósper,et al.  Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell Lines* , 1999, The Journal of Biological Chemistry.

[10]  H. Lodish,et al.  Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.

[11]  J. Johnston,et al.  Cytokine‐inducible SH2 protein‐3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N‐terminal kinase inhibitory region as well as SH2 domain , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[12]  A. Miyajima,et al.  Role of cytokine signaling molecules in erythroid differentiation of mouse fetal liver hematopoietic cells: functional analysis of signaling molecules by retrovirus-mediated expression. , 1999, Blood.

[13]  K. Okkenhaug,et al.  Socs1 binds to multiple signalling proteins and suppresses Steel factor‐dependent proliferation , 1999, The EMBO journal.

[14]  I. Wilson,et al.  Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.

[15]  H. Varmus,et al.  A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. , 1998, Genes & development.

[16]  M. Zenke,et al.  Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. , 1998, Blood.

[17]  J. Cleveland,et al.  Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. , 1998, Genes & development.

[18]  Z. Zhao,et al.  Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis , 1998 .

[19]  D. Seshasayee,et al.  GATA-1 Dominantly Activates a Program of Erythroid Gene Expression in Factor-Dependent Myeloid FDCW2 Cells , 1998, Molecular and Cellular Biology.

[20]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[21]  J. Kuźnicki,et al.  Molecular Cloning and Expression of a Mouse Brain cDNA Encoding a Novel Protein Target of Calcyclin , 1998, Journal of neurochemistry.

[22]  J. Marine,et al.  Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors , 1998, Cell.

[23]  J L Cleveland,et al.  Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways. , 1998, Genes & development.

[24]  J. Gustafsson,et al.  In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2 , 1998, Molecular and Cellular Endocrinology.

[25]  E. Price,et al.  MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes , 1998, Nature.

[26]  D. Seshasayee,et al.  Mechanisms of stem cell factor and erythropoietin proliferative co-signaling in FDC2-ER cells. , 1997, Blood.

[27]  H. Sakamoto,et al.  Cloning and characterization of novel CIS family genes. , 1997, Biochemical and biophysical research communications.

[28]  A. Kahn,et al.  Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. , 1997, Blood.

[29]  V. Broudy,et al.  Stem cell factor and hematopoiesis. , 1997, Blood.

[30]  M. Bondurant,et al.  The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. , 1997, Blood.

[31]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[32]  S. Akira,et al.  Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.

[33]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[34]  H. Lodish,et al.  The Prolactin Receptor and Severely Truncated Erythropoietin Receptors Support Differentiation of Erythroid Progenitors* , 1997, The Journal of Biological Chemistry.

[35]  A. Yoshimura,et al.  CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. , 1997, Blood.

[36]  D. Wojchowski,et al.  Mitogenic Signaling and Inhibition of Apoptosis via the Erythropoietin Receptor Box-1 Domain* , 1997, The Journal of Biological Chemistry.

[37]  T. Ley,et al.  Molecular Cloning, Chromosomal Localization, and Expression of Murine Dipeptidyl Peptidase I* , 1997, The Journal of Biological Chemistry.

[38]  J. Hoidal,et al.  Human Dipeptidyl-peptidase I , 1997, The Journal of Biological Chemistry.

[39]  H. Lodish,et al.  Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Dentelli,et al.  Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and TPO-mediated myeloid cell proliferation. , 1996, Oncogene.

[41]  Y. Yamauchi,et al.  Improved dicistronic mRNA expression vectors for efficient selection of transfectants highly expressing foreign genes. , 1996, BioTechniques.

[42]  J. Ihle,et al.  Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response , 1996, Molecular and cellular biology.

[43]  J. Krosl,et al.  Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin‐induced cell proliferation and Stat5 activation. , 1995, The EMBO journal.

[44]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[45]  E. Jost,et al.  Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. , 1995, Experimental cell research.

[46]  E. Petricoin,et al.  Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. , 1995, Science.

[47]  H. Lodish,et al.  Interaction of the erythropoietin and stem-cell-factor receptors , 1995, Nature.

[48]  I. Dusanter-Fourt,et al.  Tyrosine phosphorylation of the erythropoietin receptor: role for differentiation and mitogenic signal transduction. , 1995, Blood.

[49]  Ursula Klingmüller,et al.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.

[50]  A. Hata,et al.  Tyrosine kinases Lyn and Syk regulate B cell receptor‐coupled Ca2+ mobilization through distinct pathways. , 1994, The EMBO journal.

[51]  E. Prochownik,et al.  Differential patterns of DNA binding by myc and max proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Quelle,et al.  Localized cytosolic domains of the erythropoietin receptor regulate growth signaling and down-modulate responsiveness to granulocyte-macrophage colony-stimulating factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Berns,et al.  The pim‐1 oncogene encodes two related protein‐serine/threonine kinases by alternative initiation at AUG and CUG. , 1991, The EMBO journal.

[54]  J. Ihle,et al.  Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line. , 1982, Journal of immunology.

[55]  M. Loeffler,et al.  Effects of continuous stem cell factor administration on normal and erythropoietin‐stimulated murine hemopoiesis: Experimental results and model analysis , 1995, Stem cells.